Aegis Capital Starts Signal Genetics (SGNL) at Buy

September 9, 2014 8:40 AM EDT Send to a Friend
Aegis Capital initiated coverage on Signal Genetics (NASDAQ: SGNL) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login